| Antigenics Oncophage Well Ahead of Dendreon (NASDAQ:AGEN) - TapeBeat |
|
|
TapeBeatIn 2006, Antigenics announced top-line results from the first part of the phase III study of Oncophage in renal cell carcinoma. The trial did not meet its ... read more |